Concepedia

Michael J. Morse

MJ

Statistics

Publications

25

Citations

3.8K

H-Index

20

Active since

1982

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Cancer Genetics (United States)

North Shore University Hospital

Michael J. Morse is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and urology.

Publications per year

1982–2014

25

Publications

25

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

Cora N. Sternberg, Alan Yagoda, Howard I. Scher et al. · Cancer · 1989 · 673 citations

, , +14

Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the Urothelium

Cora N. Sternberg, Alan Yagoda, Howard I. Scher et al. · The Journal of Urology · 1985 · 660 citations

, , +6

M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Transitional Cell Carcinoma of the Urothelium

Cora N. Sternberg, Alan Yagoda, Howard I. Scher et al. · The Journal of Urology · 1988 · 628 citations

, , +6

Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection.

Guy C. Toner, David M. Panicek, R T Heelan et al. · Journal of Clinical Oncology · 1990 · 287 citations

, , +16

Penile Cancer: Relation of Extent of Nodal Metastasis to Survival

V. Srinivas, Michael J. Morse, H.W. Herr et al. · The Journal of Urology · 1987 · 274 citations

, , +13

1–5 of 25